20-4 researchers at UCLA have been named recipients of awards from the 2021 UCLA Innovation Fund Biomedical Level of competition.
These awards, up to $150,000 for each project, assist early stage study that lead to commercialization routines, which usually aren’t supported by simple analysis grants. As a result, scientists can build their systems to a stage exactly where the possibilities of achievements are considerably enhanced. All awarded initiatives get consultations from an outside the house industry and investor adviser panel, which gives specialized and professional suggestions that is crucial to technological know-how development.
The UCLA Innovation Fund was set up in 2016 by the UCLA Know-how Enhancement Team, in conjunction with the David Geffen Faculty of Medicine at UCLA, UCLA College’s divisions of bodily sciences and daily life sciences, the UCLA Samueli University of Engineering, the UCLA School of Dentistry and UCLA Well being.
The applicants’ tasks ended up evaluated on their novelty, importance and likely general public benefit, as properly as the status of the intellectual home and other variables relating to the projects’ technological feasibility and commercial opportunity.
The two tracks in the 2021 cycle had been therapeutics and medical technologies.
The award recipients for the therapeutics track:
- Peter Clark, assistant professor of molecular and health-related pharmacology Robert Damoiseaux, professor of molecular and health care pharmacology Dr. Richard Finn, professor of medicine in the division of hematology/oncology Harvey Herschman, distinguished research professor, molecular and health care pharmacology and Varghese John, professor of neurology and the principal investigator at the Drug Discovery Lab at UCLA had been regarded for their function developing a hexokinase 2 inhibitor to take care of hepatocellular carcinoma.
- Arpana Gupta, adjunct assistant professor in the division of digestive ailments Dr. Tien Dong assistant scientific professor of medicine Dr. Jonathan Jacobs assistant professor-in-residence in the division of digestive conditions and Dr. Emeran Mayer, professor of medication, physiology and psychiatry were being awarded funding for their cure battling obesity and food stuff addiction by harnessing the mind-intestine axis.
- Dr. Dinesh Rao, affiliate professor, pathology and laboratory drugs Robert Damoiseaux, professor of molecular and medical pharmacology and Neil Garg, distinguished professor in chemistry and biochemistry, acquired money for their modest molecule solution targeting RNA binding proteins in most cancers cells.
The award recipients for the medical technology monitor:
- The team guide by Dr. Renea Sturm, pediatric urologist and assistant professor of urology, joined by George Aninwene II, Peyton Tebon and Ali Khademhosseini, former professor of bioengineering, invented a novel product for urologic tissue fix.
- R. Michael van Dam and his group of Jason Jones and Ksenia Lisova designed a machine which will allow for on-desire manufacture of radiopharmaceuticals.
- The team of Glen Meyerowitz, Dr. Igor Barjaktarevic, Dr. Obi Emeruwa and Onike Williams invented a novel device which lets custom-made ventilation of every lung for individuals with acute lung injuries.
- Jeff Chiang, assistant adjunct professor and leader of the computational drugs technological know-how main worked with Dr. Srinivas Sadda to advance a diagnostic which detects macular degeneration in its early stages although intervention is nonetheless achievable.
The UCLA Innovation Fund is now accepting 2022 applications. Simply click here for much more info.